Article Versions Notes

Menichini P, Monti P, Speciale A, Cutrona G, Matis S, Fais F, Taiana E, Neri A, Bomben R, Gentile M, et al. Antitumor Effects of PRIMA-1 and PRIMA-1^Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair? Cells. 2021; 10(1):98. https://doi.org/10.3390/cells10010098

Menichini, Paola, Paola Monti, Andrea Speciale, Giovanna Cutrona, Serena Matis, Franco Fais, Elisa Taiana, Antonino Neri, Riccardo Bomben, Massimo Gentile, and et al. 2021. "Antitumor Effects of PRIMA-1 and PRIMA-1^Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?" Cells 10, no. 1: 98. https://doi.org/10.3390/cells10010098

Menichini, P., Monti, P., Speciale, A., Cutrona, G., Matis, S., Fais, F., Taiana, E., Neri, A., Bomben, R., Gentile, M., Gattei, V., Ferrarini, M., Morabito, F., & Fronza, G. (2021). Antitumor Effects of PRIMA-1 and PRIMA-1^Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair? Cells, 10(1), 98. https://doi.org/10.3390/cells10010098